Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

WCRI Publishes Interstate Variation and Trends Report on Drug Payments

Dermatological agents remained a significant cost driver, in part due to physician dispensing and delivery pharmacies, which accounted for a significant number of high-cost transactions.
Read More →
May 25, 2026

Montana Proposes Updates to Formulary and Fee Schedule, Requesting Stakeholder Feedback

A remote hearing will be held on May 28th, with comments accepted through June 5th. If enacted, changes will take effect July 1st.
Read More →
May 18, 2026

Oklahoma Enacts Law for Ibogaine Clinical Trials

Effective November 1st, the Department of Health can enter into contracts with drug developers to conduct ibogaine clinical trials.
Read More →
May 18, 2026

Connecticut Could Soon Expand Psychedelic Pilot Program

Previously limited to veterans and other specific populations, the bill could apply to any adult that meets clinical eligibility criteria.
Read More →
May 18, 2026

Louisiana Considers Psychedelic-Assisted Therapy Program

Psilocybin and ibogaine clinical trials would target opioid use disorder and treatment-resistant mental health conditions.
Read More →
May 18, 2026

Minnesota Considers Psychedelics Therapy Program

A three-year pilot program would allow for 1,000 patients annually to receive treatment for PTSD, depression, chronic pain, and more.
Read More →
May 18, 2026

NCCI Publishes 2026 State of the Line Report

While claim frequency is declining, severity is increasing, with injured workers receiving more care or more complex treatment.
Read More →
May 18, 2026

Washington Increases Penalties for Violations of Workers’ Comp Laws

Effective July 1st, certain violations of workers’ comp law will see a 12.11% increase in penalties.
Read More →
May 18, 2026

Department of Labor Expands Pharmacy Models Across Programs

This development signals a shift toward a standardized OWCP pharmacy model that could impact Longshore and Black Lung claimants.
Read More →
May 11, 2026
1 … 6 7 8 9 10 … 60

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Cybersecurity Strategies to Balance Innovation & Caution in the Age of AI

Healthesystems AVP of Information & Technology Security, Tony Brown, will speak about this topic at the 2025 IAIABC Convention.
Read More

Tracking Sub-Regulatory Changes in Workers’ Comp

Healthe’s VP of Industry and State Affairs, Sandy Shtab, shares her thoughts with Risk & Insurance magazine in a recent article.
Read More

FDA Orders Opioid Manufacturers to Update Prescribing Information for Long-Term Use

All opioid manufacturers must update their drug labeling to align with a list of notes provided by the FDA.
Read More

Burden of Proof: Unpacking Presumptions in Workers’ Comp

Exploring the expansion of presumptions in PTSD, cancers, and more.
Read More

FDA Takes Steps to Restrict Certain Kratom Products

The FDA recommended concentrated 7-OH kratom products to be rescheduled under the Controlled Substances Act.
Read More

The Emerging Role of AI in Workers’ Comp – and the Regulations Surrounding It

An expert Q&A with Sandy Shtab, VP of Industry and State Affairs, on AI in workers’ comp and the regulations surrounding it.
Read More
1 … 6 7 8 9 10 … 52
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle